IDEAYA BIOSCIENCES, INC.

Profile

Company Names

IDEAYA BIOSCIENCES, INC.

Addresses

7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA 94080

280 UTAH AVENUE, SUITE 250, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-443-6209
650-392-0422

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$111,380,520.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-01-31 
$94,019,988.00 
$94,019,988.00 
$0.00 
Equity 
1
2016-03-01 
$17,360,532.00 
$46,157,399.00 
$28,796,867.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
 
DANIELS 
DIRECTOR
SPYRYX BIOSCIENCES, INC.   |  NOHLA THERAPEUTICS INC.   |  RARECYTE, INC.   |  IDEAYA BIOSCIENCES, INC.   |  CABALETTA BIO, INC.   |  ARTIVA BIOTHERAPEUTICS, INC.   |  SBARRO HOLDINGS, INC.
JOHN 
 
DIEKMAN 
DIRECTOR
IGENICA INC   |  5AM CO-INVESTORS III, L.P.   |  PHENOMIX CORP   |  PHASERX, INC.   |  5AM CO-INVESTORS IV, L.P.   |  IGENICA BIOTHERAPEUTICS, INC   |  IDEAYA BIOSCIENCES, INC.
JOHN 
D. 
DIEKMAN 
DIRECTOR
AMBRX INC   |  PHASERX INC   |  INGENUITY SYSTEMS INC   |  PHASERX, INC.   |  IDEAYA BIOSCIENCES, INC.
MICHAEL 
P. 
DILLON 
EXECUTIVE OFFICER
IDEAYA BIOSCIENCES, INC.
JEFFREY 
 
HAGER 
EXECUTIVE OFFICER
IDEAYA BIOSCIENCES, INC.
YUJIRO 
 
HATA 
EXECUTIVE OFFICER, DIRECTOR
IDEAYA BIOSCIENCES, INC.   |  EXPANSION THERAPEUTICS, INC.   |  XENCOR INC
YUJIRO 
S. 
HATA 
DIRECTOR, EXECUTIVE OFFICER
IDEAYA BIOSCIENCES, INC.
EDWARD 
 
HU 
DIRECTOR
VIVACE THERAPEUTICS, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  IDEAYA BIOSCIENCES, INC.   |  VIELA BIO, INC.
TERRY 
 
ROSEN 
DIRECTOR
FLEXUS BIOSCIENCES, INC.   |  IDEAYA BIOSCIENCES, INC.   |  SIMCHA THERAPEUTICS HOLDING COMPANY, LLC   |  SONOMA BIOTHERAPEUTICS, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
TIMOTHY 
 
SHANNON 
DIRECTOR
TRAXIS EMERGING MARKETS EQUITY OFFSHORE FUND LTD.   |  TRAXIS EMERGING MARKETS OPPORTUNITIES OFFSHORE FUND LTD.   |  HELIX THERAPEUTICS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  VAXINNATE CORP   |  CORNOVUS PHARMACEUTICALS INC.   |  IDEAYA BIOSCIENCES, INC.   |  ARVINAS, INC.   |  INIVATA LTD   |  SIDUMA THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC   |  LAND MEDICINE INC.   |  TRITON THERAPEUTICS, INC.   |  QUARRY GLUE HOLDING CO LLC
TIM 
 
SMITH 
EXECUTIVE OFFICER
KAMINAK GOLD CORP   |  IDEAYA BIOSCIENCES, INC.   |  CELULARITY INC.   |  HRA FLATS AT AUTZEN LLC   |  SOUNDWAYS, INC.   |  COLONY LOGISTICS, INC.   |  STEPSTONE (LUXEMBOURG) SCA SICAV-RAIF - STEPSTONE PRIVATE MARKETS   |  STEPSTONE (LUXEMBOURG) SCA SICAV-RAIF - STEPSTONE PRIVATE VENTURE + GROWTH FUND   |  STEPSTONE (LUXEMBOURG) SCA SICAV-RAIF - STEPSTONE PRIVATE INFRASTRUCTURE FUND   |  FIRSTCLOSE, INC.
JEFFREY 
 
STEIN 
DIRECTOR
TRIUS THERAPEUTICS INC   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  IDEAYA BIOSCIENCES, INC.   |  FRP INVESTORS, L.P.   |  TOMATO JOS, INC.
PAUL 
 
STONE 
EXECUTIVE OFFICER
HOMOLOGY MEDICINES, INC.   |  IDEAYA BIOSCIENCES, INC.   |  EXPANSION THERAPEUTICS, INC.   |  ASSAY DEPOT INC   |  ALPHA MEDIA HOLDINGS LLC
PAUL 
A. 
STONE 
EXECUTIVE OFFICER
IDEAYA BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-31 
2016-08-26
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#